SMO and neoplasm: We revealed that the proliferation and migration of RA-FLS were remarkably enhanced by a Smo agonist (purmorphamine) and significantly suppressed by a Smo antagonist (cyclopamine), indicating that Shh signaling contributes to abnormal tumor-like behaviors, such as the growth and aggressiveness of RA-FLS [18].